scispace - formally typeset
C

Cathy Fernandes

Researcher at King's College London

Publications -  117
Citations -  5102

Cathy Fernandes is an academic researcher from King's College London. The author has contributed to research in topics: Gene expression & Autism. The author has an hindex of 37, co-authored 110 publications receiving 4380 citations. Previous affiliations of Cathy Fernandes include Guy's Hospital & Utrecht University.

Papers
More filters
Journal ArticleDOI

The Influence of Open Arm Ledges and Maze Experience in the Elevated Plus-Maze

TL;DR: It is suggested that both types of plus-maze may be measuring the same type of anxiety with different sensitivities on trial 1 (e.g., generalised anxiety or fear of open spaces); different types of anxiety on trial 2 (without ledges)--phobia/fear of heights; with ledges--not known), and trial 3 in the maze with ledge, yet another type of Anxiety.
Journal ArticleDOI

Activity-Dependent Gating of Parvalbumin Interneuron Function by the Perineuronal Net Protein Brevican.

TL;DR: It is shown that the PNN protein Brevican is a critical regulator of interneuron plasticity and simultaneously controls cellular and synaptic forms of plasticity in PV+ cells by regulating the localization of potassium channels and AMPA receptors.
Journal ArticleDOI

Factor Analysis Shows That Female Rat Behaviour Is Characterized Primarily by Activity, Male Rats Are Driven by Sex and Anxiety

TL;DR: The results suggest caution should be exercised in interpreting the results from female rats in tests validated on males because the primary controlling factor may be different.
Journal ArticleDOI

Cannabis use in young people: the risk for schizophrenia.

TL;DR: Evidence from both epidemiological and animal studies indicates that cannabis use during adolescence carries particular risk in addiction, and further studies are warranted given the increase in the concentration of the main active ingredient in street preparations of cannabis and a decreasing age of first-time exposure to cannabis.
Journal ArticleDOI

Copy number variations in neurodevelopmental disorders.

TL;DR: The discovery of pathogenic CNVs provide new opportunities for translation leading to patent benefit, including improvements in clinical genetic diagnosis and genetic counselling, the possibility of clinician decision-making tools for risk prediction, and the identification of drug targets and implementation of personalised medicine using stratification by genotype.